The administration of ATO in APL cells causes oxidation, sumoylation and subsequently poly-ubiquitination and proteasomal degradation of the PML-RARα protein (Figure 1), leading to the re-formation of nuclear bodies and the induction of senescence [21,22,23]. Here, RARA is linked to acute promyelocytic leukemia.